Aurora Cannabis (ACB) Tops Q2 Net Loss of $75.14M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures gain on tech rebound, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls 1% as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Aurora Cannabis Inc. (ACB:CN) (ACB) PT Lowered to Cdn$7.60 at Cantor Fitzgerald
February 11, 2022 6:40 AM ESTCantor Fitzgerald analyst Pablo Zuanic lowered the price target on Aurora Cannabis Inc. (ACB:CN) (NASDAQ: ACB) to Cdn$7.60 (from Cdn$10.75) while maintaining a Neutral rating.
The analyst commented, "ACB management is pleased with progress on the three outlined strategic pillars (grow the... More
